Institute Gustave Roussy, France
Lung tumors effectively treated by radiofrequency ablation
Published in Law and Health Weekly, October 7th, 2006
According to a recent report, researchers in France conducted a study "to prospectively evaluate the local efficacy of RF ablation of lung neoplasms, with a minimum follow-up period of 1 year. Sixty patients (34 men and 26 women; age range, 27-81 years; mean age, 66 years) with 100 lung tumors gave written informed consent to be enrolled in a prospective study that was approved by the local ethics committee. There were 5 or fewer tumors per patient, each with a diameter of <40 mm (mean±standard deviation, 17 mm±10)."
"RF ablation was performed in tumors by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Anormed
Anormed board recommends shareholders reject hostile Genzyme offer - Bristol-Myers Squibb
Injunction ordered in Plavix patent infringement case; Apotex to stop sales of generic - British Columbia Children's Hospital, Vancouver, Canada
Breathing circuit filters increase the deadspace effect in children under 2 years - Duke University, U.S.
Safety concerns and treatment nonadherence may lead to legal leverage - Inovio Biomedical
Inovio's electroporation patent estate expanded with the allowance of claims in Europe - James Martin 21st Century School, U.K.
Reports from the United Kingdom and United States describe recent advances in HIV/AIDS research - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
